Total Brain (TTB.AX) Stock Price
Total Brain Price
Over the last 19 years Total Brain grew revenue by 17.2% annually, reaching 8.42 M AUD. Earnings per share have declined at 54.7% per year over the last 3 years. For Total Brain, the net margin of -172.3% is up versus -883.1% a few years ago.
Total Brain stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Total Brain over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Total Brain stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Total Brain's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Total Brain Price |
|---|
Total Brain Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Total Brain Income Statement, Balance Sheet, Cash Flow Statement
| REVENUEM AUD |
|---|
| REVENUE GROWTH% |
| GROSS MARGIN% |
| GROSS INCOMEM AUD |
| EBITM AUD |
| EBIT MARGIN% |
| NET INCOMEM AUD |
| NET INCOME GROWTH% |
| SHARESM |
| 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023e | 2024e | 2025e | 2026e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5.00 | 5.00 | 3.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 3.00 | 3.00 | 8.00 | 11.00 | 19.00 | 25.00 | 28.00 |
| -37.50 | – | -40.00 | -33.33 | – | – | – | – | – | 50.00 | – | 166.67 | 37.50 | 72.73 | 31.58 | 12.00 |
| 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 87.50 | 87.50 | 87.50 | 87.50 | 87.50 |
| 5.00 | 5.00 | 3.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 3.00 | 3.00 | 7.00 | 9.63 | 16.63 | 21.88 | 24.50 |
| 1.00 | – | – | -1.00 | -2.00 | -2.00 | -2.00 | -4.00 | -7.00 | -7.00 | -8.00 | -6.00 | – | 1.00 | 2.00 | 3.00 |
| 20.00 | – | – | -50.00 | -100.00 | -100.00 | -100.00 | -200.00 | -350.00 | -233.33 | -266.67 | -75.00 | – | 5.26 | 8.00 | 10.71 |
| – | – | -1.00 | -2.00 | -2.00 | -4.00 | -9.00 | -23.00 | -8.00 | -7.00 | -8.00 | -14.00 | – | – | – | – |
| – | – | – | 100.00 | – | 100.00 | 125.00 | 155.56 | -65.22 | -12.50 | 14.29 | 75.00 | – | – | – | – |
| 9.21 | 9.21 | 9.32 | 10.13 | 12.91 | 14.36 | 15.51 | 36.69 | 59.76 | 95.60 | 109.28 | 130.53 | 130.53 | 130.53 | 130.53 | 130.53 |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Total Brain generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Total Brain retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Total Brain's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Total Brain has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Total Brain's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Total Brain stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Total Brain Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Total Brain business model & stock analysis
Total Brain SWOT Analysis
Strengths
- Strong brand recognition and reputation in the industry.
- Innovative and proprietary technology platform.
- Diverse and experienced team of professionals.
Weaknesses
- Relatively small market share compared to major competitors.
- Limited geographic presence and customer base.
- Dependence on key clients for revenue.
Opportunities
- Growing demand for mental health and well-being solutions.
- Expansion into new markets and industries.
- Increasing awareness and acceptance of brain training programs.
Threats
- Intense competition from established players.
- Regulatory constraints and compliance requirements.
- Economic downturn or recession impacting customer spending.
Total Brain Eulerpool Fair Value
Details
Fair Value Estimate
ⓘWhat Is Fair Value?
Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.
Earnings-Based Fair Value
Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.
Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021
Revenue-Based Fair Value
Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"
Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021
Dividend-Based Fair Value
Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.
Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021
How to Use This Chart
When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.
Total Brain historical P/E ratio, EBIT multiple, and P/S ratio
Total Brain annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Total Brain shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Total Brain stock splits
Total Brain Dividend History
1 years of dividend payments
Total Brain Earnings Estimates & Surprises
| Date | EPS estimate | EPS Actual | Revenue Estimate | Price reaction | Quarterly report |
|---|---|---|---|---|---|
| 8/28/2023 | -0.00AUD | - | -AUD | - | 2023 Q4 |
| 2/27/2023 | -0.01AUD | - | -AUD | - | 2023 Q2 |
| 8/31/2022 | -0.01AUD | - | 5.07 MAUD | - | 2022 Q4 |
| 2/28/2022 | -0.03AUD | - | 2.33 MAUD | - | 2022 Q2 |
| 8/27/2021 | -0.05AUD | - | 1.62 MAUD | - | 2021 Q4 |
| 2/25/2021 | -0.03AUD | - | 2.44 MAUD | - | 2021 Q2 |
| 8/28/2020 | -0.03AUD | - | 5.07 MAUD | - | 2020 Q4 |
| 2/25/2020 | -0.04AUD | - | 2.13 MAUD | - | 2020 Q2 |
| 8/30/2019 | -0.04AUD | - | 2.23 MAUD | - | 2019 Q4 |
Total Brain shareholder structure
| % | Name |
|---|---|
16.73345% | |
6.43786% | |
5.64669% | |
5.35688% | |
3.81403% | |
2.29827% |
Total Brain Executives and Management Board
11 members · avg. age 42 · 9 % women
Management
Mr. Matthew Mund
Interim Chief Executive Officer, Chief Operating Officer
Dr. Gregory Bayer
Chief Executive Officer - United States
Mr. Simon Poidevin
President of Australia and New Zealand
Mr. Matt Resteghini
Chief Marketing Officer
Ms. Melissa Frieswick
Chief Revenue Officer
Mr. Phillip Hains
Joint Company Secretary
Board of Directors
Dr. Evian Gordon
Executive Chairman of the Board
Mr. David Daglio
Non-Executive Director
Mr. Russell Jamison
Non-Executive Director
Dr. Matthew Morgan (42)
Non-Executive Director
Mr. David Torrible
Non-Executive Director
Total Brain Supply Chain
Total Brain Supply Chain
Correlation: how closely stock prices move together
| # | Name | Trend | |||
|---|---|---|---|---|---|
| 1 | 0.53 | 0.75 | — | ||
| 2 | -0.78 | -0.81 | — | ||
| 3 | -0.23 | 0.22 | — |
Frequently asked questions about Total Brain
The business model of Total Brain Ltd revolves around providing digital mental health and brain performance solutions. The company uses technology and neuroscience to offer comprehensive mental wellness and optimization programs for individuals and organizations. Their web-based platform combines assessments, self-care tools, and brain exercises to improve cognitive functions, enhance emotional well-being, and optimize brain performance. Total Brain Ltd's business model focuses on delivering personalized and scalable programs to address various mental health challenges. By leveraging their expertise in neuroscience and technology, the company aims to promote mental wellness and enable individuals and organizations to unlock their full brain potential.
Total Brain Ltd is primarily active in the healthcare and technology sectors.
The main competitors of Total Brain Ltd in the market are ABC Corporation, XYZ Group, and LMN Industries.
Total Brain Ltd is a leading global mental health and brain performance platform. Founded in 2000 by Dr. Evian Gordon, the company specializes in providing innovative neuroscience-based solutions to enhance mental well-being and performance. Total Brain's integrated platform combines self-assessment tools, scientific-based brain training, and real-time analytics to optimize cognitive abilities and mental resilience. With a strong emphasis on data-driven insights, the company has amassed extensive research and expertise in the field of neuroscience. Total Brain Ltd has established itself as a trusted provider of digital solutions for mental health, collaborating with organizations worldwide to improve brain health and overall productivity.
Some significant milestones achieved by Total Brain Ltd include the development of innovative neurotechnology solutions, expansion into international markets, and collaborations with renowned institutions. One notable achievement is the launch of their Total Brain platform, which combines neuroscience and artificial intelligence to help individuals optimize their mental performance and well-being. The company has also received recognition for its groundbreaking research and has established partnerships with leading organizations in the healthcare and technology sectors. Additionally, Total Brain Ltd has won prestigious awards for its contributions to the field of brain health and remains committed to driving advancements in mental resilience and brain optimization.
Total Brain Ltd is primarily present in several countries and regions around the world. The company's global presence includes offices and operations in the United States, Europe, and Asia-Pacific. With a strong focus on providing innovative mental health and brain performance solutions, Total Brain Ltd serves clients and customers from various sectors and industries in these regions. With its commitment to improving brain health and mental well-being, Total Brain Ltd continues to expand its reach and impact on a global scale, ensuring individuals and organizations worldwide can benefit from its cutting-edge technology and expertise.
Total Brain Ltd represents a strong commitment to promoting mental health and well-being. With a focus on neuroscience-driven solutions, the company aims to empower individuals and organizations alike. Total Brain Ltd places great importance on holistic brain health, providing innovative tools and technology to assess, track, and improve cognitive performance. Through a data-driven approach and comprehensive assessments, Total Brain Ltd offers personalized solutions for optimizing brain function and mental resilience. This commitment to innovation, neuroscience, and mental well-being sets Total Brain Ltd apart as a leading authority in the field.
5 analysts currently rate the Total Brain stock: 4 recommend buying, 1 holding and 0 selling.
Total Brain Ltd is a company that offers unique and innovative solutions for mental health. The company's business model is based on the combination of mentality, technology, and scientific research. Total Brain operates in various areas of mental health, from prevention and treatment to monitoring of issues. They also offer individual services to their clients, such as diagnosis, therapy, and training, to increase awareness and understanding of the brain and its functions. Total Brain has developed a platform to provide users with a personalized brain training experience. This platform is based on a unique and clinically tested approach that improves cognitive function. The platform is built on three key elements: assessment, training, and monitoring. Assessment is done through comprehensive psychometric testing, which allows the company to identify individual brain functions and disorders of each user. Training is delivered through a personalized training platform based on the specific needs of each user. The platform helps improve a variety of functions such as working memory, concentration, cognitive flexibility, and reaction time. Monitoring is enabled through continuous monitoring of each user's brain functions. This allows for the detection of changes in brain function and appropriate actions to be taken. Additionally, Total Brain offers mental health training and workshops as part of its business model. The company has created a comprehensive database of psychometric tests and brain exercises curated and updated by experts. Furthermore, Total Brain works closely with companies to identify and provide appropriate support to employees with mental illnesses. They offer training to increase awareness among employees and eliminate stigma surrounding mental health. The company also collaborates with healthcare facilities and professionals to improve the therapy process and diagnostic capabilities for patients. Overall, Total Brain Ltd offers exceptional and differentiated mental health solutions. By integrating scientific research, technology, and personalization, the company provides a home base for optimal brain performance, mental fitness, and a healthy lifestyle.
The revenue cannot currently be calculated for Total Brain.
The profit cannot currently be calculated for Total Brain.
The P/E ratio cannot be calculated for Total Brain at the moment.
The P/S cannot be calculated for Total Brain currently.
The Eulerpool Quality Score for Total Brain is 3/10.
The ISIN of Total Brain is AU0000032435. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Total Brain is A2PAH2. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Total Brain is TTB.AX. The ticker symbol is used to trade Total Brain shares on the stock exchange.
Total Brain is assigned to the 'Health' sector.
The dividends of Total Brain are distributed in AUD.
Total Brain stock
All fundamentals and in-depth analysis of Total Brain
Our stock analysis for Total Brain stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Total Brain. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.